Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis

被引:0
|
作者
Pham, Hoang Nam [1 ]
Pham, Linh [2 ]
Sato, Keisaku [3 ]
机构
[1] Vietnam Acad Sci & Technol, Univ Sci & Technol Hanoi, Dept Life Sci, Hanoi, Vietnam
[2] Texas A&M Univ, Dept Sci & Math, Cent Texas, Killeen, TX USA
[3] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
关键词
deconvolution analysis; CIBERSORTx; primary sclerosing cholangitis; primary biliary cholangitis; hepatic cell landscape; PLASMA-CELLS; CHOLANGIOCYTES; ACTIVATION; EXPRESSION; DAMAGE;
D O I
10.3389/fmed.2024.1327973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are characterized by ductular reaction, hepatic inflammation, and liver fibrosis. Hepatic cells are heterogeneous, and functional roles of different hepatic cell phenotypes are still not defined in the pathophysiology of cholangiopathies. Cell deconvolution analysis estimates cell fractions of different cell phenotypes in bulk transcriptome data, and CIBERSORTx is a powerful deconvolution method to estimate cell composition in microarray data. CIBERSORTx performs estimation based on the reference file, which is referred to as signature matrix, and allows users to create custom signature matrix to identify specific phenotypes. In the current study, we created two custom signature matrices using two single cell RNA sequencing data of hepatic cells and performed deconvolution for bulk microarray data of liver tissues including PSC and PBC patients.Methods Custom signature matrix files were created using single-cell RNA sequencing data downloaded from GSE185477 and GSE115469. Custom signature matrices were validated for their deconvolution performance using validation data sets. Cell composition of each hepatic cell phenotype in the liver, which was identified in custom signature matrices, was calculated by CIBERSORTx and bulk RNA sequencing data of GSE159676. Deconvolution results were validated by analyzing marker expression for the cell phenotype in GSE159676 data.Results CIBERSORTx and custom signature matrices showed comprehensive performance in estimation of population of various hepatic cell phenotypes. We identified increased population of large cholangiocytes in PSC and PBC livers, which is in agreement with previous studies referred to as ductular reaction, supporting the effectiveness and reliability of deconvolution analysis in this study. Interestingly, we identified decreased population of small cholangiocytes, periportal hepatocytes, and interzonal hepatocytes in PSC and PBC liver tissues compared to healthy livers.Discussion Although further studies are required to elucidate the roles of these hepatic cell phenotypes in cholestatic liver injury, our approach provides important implications that cell functions may differ depending on phenotypes, even in the same cell type during liver injury. Deconvolution analysis using CIBERSORTx could provide a novel approach for studies of specific hepatic cell phenotypes in liver diseases.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation
    Visseren, T.
    Murad, S. Darwish
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2017, 31 (02) : 187 - 198
  • [22] Hepatic eosinophilic infiltration in primary sclerosing cholangitis
    Marek Hartleb
    Maciej Kajor
    Roman Kaczor
    Andrzej Nowak
    Journal of Gastroenterology, 1998, 33 : 134 - 135
  • [23] Hepatic eosinophilic infiltration in primary sclerosing cholangitis
    Hartleb, M
    Kajor, M
    Kaczor, R
    Nowak, A
    JOURNAL OF GASTROENTEROLOGY, 1998, 33 (01) : 134 - 135
  • [24] Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
    Bergquist, A
    Ekbom, A
    Olsson, R
    Kornfeldt, D
    Lööf, L
    Danielsson, Å
    Hultcrantz, R
    Lindgren, S
    Prytz, H
    Sandberg-Gertzén, H
    Almer, S
    Granath, F
    Broomé, U
    JOURNAL OF HEPATOLOGY, 2002, 36 (03) : 321 - 327
  • [25] Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting
    Dustin E. Bosch
    Yoh Zen
    Sarag A. Boukhar
    Yongjun Liu
    Lin Cheng
    Matthew M. Yeh
    Virchows Archiv, 2021, 479 : 1131 - 1143
  • [26] Evaluation of esophageal motor functions in patients diagnosed with primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis
    Gokbulut, Volkan
    Ozturk, Omer
    Akdogan, Meral
    Kaplan, Mustafa
    Gokcan, Hale
    Kacar, Sabite
    Gokbulut, Puren
    Ari, Derya
    Turan, Dilara
    CUKUROVA MEDICAL JOURNAL, 2022, 47 (01): : 21 - 28
  • [27] Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting
    Bosch, Dustin E.
    Zen, Yoh
    Boukhar, Sarag A.
    Liu, Yongjun
    Cheng, Lin
    Yeh, Matthew M.
    VIRCHOWS ARCHIV, 2021, 479 (06) : 1131 - 1143
  • [28] Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis
    Tinmouth, J
    Lee, M
    Wanless, IR
    Tsui, FWL
    Inman, R
    Heathcote, EJ
    LIVER, 2002, 22 (03): : 228 - 234
  • [29] Primary sclerosing cholangitis
    Stiehl, A
    INTERNIST, 2004, 45 (01): : 27 - +
  • [30] Primary sclerosing cholangitis
    Manns, Michael P.
    Bergquist, Annika
    Karlsen, Tom H.
    Levy, Cynthia
    Muir, Andrew J.
    Ponsioen, Cyriel
    Trauner, Michael
    Wong, Grace
    Younossi, Zobair M.
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):